for Forensic Pathology Fellows and Toxicologists - HYBRID 2025
Drug toxicity is one of the leading causes of death in the United States. Comprehensive death investigations of suspected drug-involved deaths include comprehensive scene investigation, a forensic autopsy and forensic toxicology testing. Information from the scene and history allows the forensic pathologist to ensure that the correct samples are collected at autopsy and the appropriate testing panels are selected for testing. Evidence collected at autopsy may indicate the involvement of drugs or other toxic substances not indicated from the scene. Once the test results are available, forensic pathologists and toxicologists work together to interpret the toxicology findings in the context of the case and help ensure that the presence of drugs is given the appropriate weight in the pathologist’s certification of the death.This course has been designed to provide an overview of the investigation of suspected drug caused and related deaths, the best practices for the pathologist and toxicologist to work together, best practices in toxicological testing, and the interpretation of the results.
The faculty consists of experienced medicolegal death investigators, forensic pathologists and toxicologists, who will review the investigation process, indicators of drug involvement from scene examination, the forensic autopsy and review the forensic pharmacology and toxicology of the major drug classes involved in drug deaths in 2025. This year, we have packed the agenda with some of the best presenters, forensic pathologists, and forensic toxicologists in the world! We welcome industry leading Forensic Pathologists and Medical Examiners, as well as Dr. Barry Logan, Forensic Toxicologist and Chief Scientist with NMS Labs and CFSRE.
The course features sections on involvement in drug related deaths of opioids, CNS depressants, stimulants, antidepressants and antipsychotics, novel psychoactive substances including hallucinogens, opioids and cannabinoids, anticonvulsants, alcohol and ketoacidosis, and other topics. Each session in structured to review the basics of the pharmacology, adverse effects, and guidance to interpretation of drug concentrations, and concludes with the perspectives of leading forensic pathologists. The program also includes an in-depth consideration of postmortem redistribution, and other factors that affect interpretation.
The program concludes with a day-visit to a national forensic toxicology reference laboratory (NMS Labs) where the attendees will have the opportunity to shadow forensic toxicologists as they review cases and data and explain the process for reporting results.
This highly interactive program encourages attendees to discuss their own cases, and receive feedback from our toxicology panel, and forensic experts.
This year's event will be held at the brand new, state-of-the-art, CFSRE laboratory in Horsham, PA, right outside of Philadelphia. If, however, you are unable to personally join, the Postmortem Interpretive Toxicology Course is also offered through state of the art, hybrid technology. The HYBRID, Online Version will feature a live, simultaneous broadcast of the presentations from the podium at the Mutter Museum, with the opportunity for virtual interaction with on-site attendees and faculty through a Q&A window and chat feature. This mode is best suited to participants who are unable to travel to in-person meetings or attendees over the allowable capacity of the conference room.
CFSRE offers this training opportunity only one time per year. The 2025 Postmortem Toxicology Training, with its world-leading experts and expertise, should not be missed! We look forward to your registration and attendance.
Dates: Monday, September 8th, 2025 from 8:00am - 5:00pm ET Tuesday, September 9th, 2025 from 8:00am - 5:00pm ET Wednesday, September 10th, 2025 from 8:00am - 5:00pm ET Thursday, September 11th, 2025 from 8:00am - 5:00pm ET Friday, September 12th, 2025 from 8:00am - 4:00pm ET Registration: $1800 per person *All presentations must be attended to receive credit |